Spot Urine Sodium as Triage for Effective Diuretic Infusion in an Ambulatory Heart Failure Unit

Journal of Cardiac Failure

Volumn 24, Issue 6, 2018, Pages 349-354

  Brinkley, D Marshall ^a   Burpee, Laura J ^b   Chaudhry, Sunit Preet ^c   Smallwood, Jennifer A ^c   Lindenfeld, JoAnn ^a   Lakdawala, Neal K ^b   Desai, Akshay S ^b   Stevenson, Lynne W ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c St Vincent Heart Center of Indiana   (United States)

Author keywords

Heart failure; hospitalization; outcomes; urine sodium

Indexed keywords

FUROSEMIDE; SODIUM; BIOLOGICAL MARKER; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; FEMALE; HEART FAILURE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFUSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SODIUM URINE LEVEL; URINE VOLUME; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OUTPATIENT DEPARTMENT; PROCEDURES; URINALYSIS; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; BIOMARKERS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FUROSEMIDE; HEART FAILURE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SODIUM; TRIAGE; URINALYSIS;

EID: 85042183219     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2018.01.009     Document Type: Article

References (29)

1. Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–360.
2. Heidenreich, P.A., Albert, N.M., Allen, L.A., Bluemke, D.A., Butler, J., Fonarow, G.C., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6 (2013), 606–619.
3. Jencks, S.F., Williams, M.V., Coleman, E.A., Rehospitalizations among patients in the Medicare fee-for-service program. NEJM 360 (2009), 1418–1428.
4. Buckley, L.F., Carter, D.M., Matta, L., Cheng, J.W., Stevens, C., Belenkiy, R.M., et al. Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit. JACC Heart Fail 4 (2016), 1–8.
5. Hebert, K., Dias, A., Franco, E., Tamariz, L., Steen, D., Arcement, L.M., Open access to an outpatient intravenous diuresis program in a systolic heart failure disease management program. Congest Heart Fail 17 (2011), 309–313.
6. Lazkani, M., Ota, K.S., The role of outpatient intravenous diuretic therapy in a transitional care program for patients with heart failure: a case series. J Clin Med Res 4 (2012), 434–438.
7. Makadia, S., Simmons, T., Augustine, S., Kovell, L., Harris, C., Chibungu, A., Kapil, P., The diuresis clinic: a new paradigm for the treatment of mild decompensated heart failure. Am J Med 128 (2015), 527–531.
8. Ryder, M., Murphy, N.F., McCaffrey, D., O'Loughlin, C., Ledwidge, M., McDonald, K., Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail 10 (2008), 267–272.
9. Buckley, L.F., Seoane-Vazquez, E., Cheng, J.W.M., Aldemerdash, A., Cooper, I.M., Matta, L., et al. Comparison of ambulatory, high-dose, intravenous diuretic therapy to standard hospitalization and diuretic therapy for treatment of acute decompensated heart failure. Am J Cardiol 118 (2016), 1350–1355.
10. Singh, D., Shrestha, K., Testani, J.M., Verbrugge, F.H., Dupont, M., Mullens, W., Tang, W.H., Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 20 (2014), 392–399.
11. Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. NEJM 364 (2011), 797–805.
12. Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006), 247–254.
13. Testani, J.M., Brisco, M.A., Turner, J.M., Spatz, E.S., Bellumkonda, L., Parikh, C.R., Tang, W.H., Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 7 (2014), 261–270.
14. Brater, D.C., Diuretic therapy. NEJM 339 (1998), 387–395.
15. Testani, J.M., Hanberg, J.S., Cheng, S., Rao, V., Onyebeke, C., Laur, O., et al. Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure. Circ Heart Fail, 9, 2016, e002370.
16. Wilcox, C.S., Mitch, W.E., Kelly, R.A., Skorecki, K., Meyer, TW., Friedman, P.A., Souney, P.F., Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 102 (1983), 450–458.
17. Valente, M.A.E., Voors, A.A., Damman, K., Van Veldhuisen, D.J., Massie, B.M., O'Connor, C.M., et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J 35 (2014), 1284–1293.
18. Kaissling, B., Bachmann, S., Kriz, W., Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol 248 (1985), F374–F381.
19. Brenner, B.M., Rector, F.C., Skorecki, K., Chertow, G.M., Marsden, P.A., Taal, M.W., Yu, A.S.L., (eds.) Brenner and Rector's the kidney, 10th ed, 2016, Elsevier, Philadelphia.
20. Schrier, R.W., Blood urea nitrogen and serum creatinine: not married in heart failure. Circ Heart Fail 1 (2008), 2–5.
21. Schrier, R.W., Abraham, W.T., Hormones and hemodynamics in heart failure. NEJM 341 (1999), 577–585.
22. Gheorghiade, M., Abraham, W.T., Albert, N.M., Gattis Stough, W., Greenberg, B.H., O'Connor, C.M., et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 28 (2007), 980–988.
23. Ferreira, J.P., Girerd, N., Medeiros, P.B., Santos, M., Carvalho, H.C., Bettencourt, P., et al. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect. Clin Res Cardiol 105 (2016), 489–507.
24. Dries, D.L., Exner, D.V., Domanski, M.J., Greenberg, B., Stevenson, L.W., The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35 (2000), 681–689.
25. Keenan, P.S., Normand, S.L., Lin, Z., Drye, E.E., Bhat, K.R., Ross, J.S., et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 1 (2008), 29–37.
26. Khazanie, P., Heizer, G.M., Hasselblad, V., Armstrong, P.W., Califf, R.M., Ezekowitz, J., et al. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models. Am Heart J 170 (2015), 290–297 e1.
27. Saito, M., Negishi, K., Marwick, T.H., Meta-analysis of risks for short-term readmission in patients with heart failure. Am J Cardiol 117 (2016), 626–632.
28. Centers for Medicare and Medicaid Services, Clinical laboratory fee schedule. Available at https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files.html, 2016.
29. Verbrugge, F.H., Nijst, P., Dupont, M., Penders, J., Tang, W.H.W., Mullens, W., Urinary composition during decongestive treatment in heart failure with reduced ejection fraction. Circ Heart Fail 7 (2014), 766–772.